Coherus Biosciences reported $21.09M in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 10.77M 3.89M
Aerie Pharmaceuticals AERI:US $ 7.88M 0.41M
Akebia Therapeutics AKBA:US $ 19.47M 14.12M
Alnylam Pharmaceuticals ALNY:US $ 54.92M 18.51M
Amarin AMRN:US $ 90.75M 24.17M
Amgen AMGN:US $ 1403M 37M
Baxter International BAX:US 1.22B 23M
Biogen BIIB:US $ 398.7M 190.5M
Bluebird Bio BLUE:US $ 28.35M 2.47M
Bristol Myers Squibb BMY:US $ 2944M 5M
Coherus Biosciences CHRS:US $ 21.09M 4.93M
Endo International Ordinary Shares ENDP:US $ 101.01M 22.12M
Fujifilm 4901:JP 251.32B 19.85B
Horizon Pharma HZNP:US $ 67.01M 36.89M
Ironwood Pharmaceuticals IRWD:US $ 0.53M 0.4M
JAZZ PHA JAZZ:US $ 73.34M 26.96M
LG Chem 051910:KS 4690.57B 948.43B
Merk MRK:US $ 3715M 894M
Myriad Genetics MYGN:US $ 27.1M 2.5M
Teva Pharmaceutical TEVA:IT 1.75B 64M
Zoetis ZTS:US $ 402M 34M